Non-hormonal Copper IUD

Showing 41-48 of 64 results

Research roundup: August 2021 edition

Provision of medication abortion via telehealth, updated CDC treatment guidelines for sexually-transmitted infections, barriers to IUD and implant access for adolescent and young adult patients, and more.

Research roundup: July 2021 edition

Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.

Research roundup: June 2021 edition

In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.

Research roundup: May 2021 edition

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Research roundup: February 2021 edition

Comparable effectiveness of Levonorgestrel and copper IUDs as emergency contraception, use of the Natural Cycles app for fertility awareness contraceptive method, transcutaneous electrical nerve stimulation as highly effective pain management in medication abortion care, and more.

Research roundup: December 2020 edition

An analysis of the use of verbal anesthesia vs. oral tramadol for pain management in IUD placement, potential effectiveness of DMPA as a self-bridging emergency contraceptive, the importance of access to PrEP among people at risk of HIV infection through receptive vaginal intercourse, and more.

Research roundup: October 2020 edition

IUD use and a demonstrated decreased risk of ovarian cancer, salpingectomy vs. tubal ligation for sterilization, benefits of non-medical treatment options for recurrent bacterial vaginosis, and more.

Research roundup: September 2020 edition

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.
  • Previous
  • 4
  • 5
  • 6(current)
  • 7
  • 8
  • Next